Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy

PloS One
Huai LiuHai-Qiang Mai

Abstract

Treatment outcomes vary greatly in patients with nasopharyngeal carcinoma (NPC). The purpose of this study is to evaluate the influence of radiation and chemotherapy drug action pathway gene polymorphisms on the survival of patients with locoregionally advanced NPC treated with cisplatin- and fluorouracil-based chemoradiotherapy. Four hundred twenty-one consecutive patients with locoregionally advanced NPC were prospectively recruited. We utilized a pathway approach and examined 18 polymorphisms in 13 major genes. Polymorphisms were detected using the LDR-PCR technique. Multifactor dimensionality reduction (MDR) analysis was performed to detect potential gene-gene interaction. After adjustment for clinicopathological characteristics, overall survival was significantly decreased in patients with the MPO rs2243828 CT/CC genotype (HR=2.453, 95% CI, 1.687-3.566, P<0.001). The ERCC1 rs3212986 CC (HR=1.711, 95% CI, 1.135-2.579, P=0.010), MDM2 rs2279744 GT/GG (HR=1.743, 95% CI, 1.086-2.798, P=0.021), MPO rs2243828 CT/CC (HR=3.184, 95% CI, 2.261-4.483, P<0.001) and ABCB1 rs2032582 AT/AA (HR=1.997, 95% CI, 1.086-3.670, P=0.026) genotypes were associated with poor progression-free survival. Prognostic score models based on independent pr...Continue Reading

References

Jan 1, 1992·Advances in Cancer Research·C Basilico, D Moscatelli
Oct 5, 1993·Toxicology·A H Hofstra, J P Uetrecht
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Al-SarrafJ F Ensley
Aug 27, 1999·Clinical Biochemistry·M KhannaF Barany
Dec 23, 1999·Current Opinion in Hematology·C C WinterbournA J Kettle
Mar 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·S HoffmeyerU Brinkmann
May 29, 2000·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·S O Suzuki, T Iwaki
Aug 3, 2001·International Journal of Radiation Oncology, Biology, Physics·J MaH Q Min
Jan 31, 2002·Annual Review of Medicine·Michael M Gottesman
Oct 25, 2002·International Journal of Cancer. Journal International Du Cancer·Wenfu LuDongxin Lin
Jan 1, 2003·Seminars in Cancer Biology·Dan Michael, Moshe Oren
Feb 4, 2003·Nature Reviews. Cancer·Andrei V Gudkov, Elena A Komarova
Jul 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·John D Storey, Robert Tibshirani
Aug 7, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wei ZhouDavid C Christiani
Oct 20, 2004·Cancer Research·Jiyoung AhnChristine B Ambrosone
Nov 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Partha M Das, Rakesh Singal
Feb 4, 2005·Journal of Leukocyte Biology·Seymour J Klebanoff
Oct 26, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rupert LangerHeinz Höfler
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Henrik GréenCurt Peterson
Jun 21, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xifeng WuJaffer A Ajani
Jul 11, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christoph ThussbasNadia Harbeck
Sep 8, 2006·The New England Journal of Medicine·Ken A OlaussenUNKNOWN IALT Bio Investigators
Oct 31, 2006·BMC Cancer·Damali N MartinStefan Ambs
May 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gangqiao ZhouFuchu He
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tomonori NakazatoMasahiro Kizaki
May 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Irina GryshchenkoInge Tinhofer
Jul 22, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas C KrivakUNKNOWN Gynecologic Oncology Group Phase III Trial
Mar 17, 2009·Biochimica Et Biophysica Acta·King Leung Fung, Michael M Gottesman
Apr 22, 2009·Journal of Cellular and Molecular Medicine·Roman HrstkaBorivoj Vojtesek
Sep 16, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine B AmbrosoneKathy S Albain
Apr 30, 2010·Chinese Journal of Cancer·Joseph Tien Seng WeeChao-Nan Qian
Oct 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kouya ShiraishiHideo Kunitoh
Nov 5, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J PanderH-J Guchelaar
Dec 7, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Li LiuDongxin Lin
Jan 29, 2011·Chinese Journal of Cancer·Su-Mei CaoChao-Nan Qian
Apr 14, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yue-Feng WenHai-Qiang Mai
May 31, 2011·International Journal of Radiation Oncology, Biology, Physics·Jong-Mu SunKeunchil Park

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
genotyping

Software Mentioned

MDR
SPSS

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis